WeVote
Log In

Bill

Bill

SJR 21

Designates March of each year as "Fibromuscular Dysplasia Awareness Month."

2026-2027 Regular Session Introduced by Nilsa Cruz-Perez and 2 co-sponsors

New Jersey designates March annually as Fibromuscular Dysplasia Awareness Month to increase recognition of this rare vascular disease.

Introduced in the Senate, Referred to Senate Health, Human Services and Senior Citizens Committee
0
WeVote Research Nonpartisan
Bill Summary · SJR 21

Legislative bill overview

SJR 21 designates March of each year as "Fibromuscular Dysplasia Awareness Month" in New Jersey. The bill is a ceremonial resolution that recognizes and promotes awareness of fibromuscular dysplasia (FMD), a rare vascular disease affecting arteries and veins.

Why is this important

Fibromuscular dysplasia is a relatively unknown condition that can cause serious complications including stroke, heart attack, and kidney failure if undiagnosed. Designated awareness months increase public and medical community recognition of rare diseases, potentially improving early detection and patient outcomes.

Potential points of contention

  • Resource allocation concerns: Critics may question whether symbolic designations justify legislative time when substantive funding or research initiatives could have greater practical impact
  • Precedent and proliferation: Approval could encourage numerous similar awareness month designations, raising questions about selectivity among health conditions
  • Scope of condition: Some may debate whether fibromuscular dysplasia warrants state-level recognition given its rarity (affects approximately 1 in 1,500 to 5,000 people), though advocates would counter that rare disease recognition is precisely why such designations matter

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.